BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22319577)

  • 1. Accumulation of CCR4⁺CTLA-4 FOXP3⁺CD25(hi) regulatory T cells in colon adenocarcinomas correlate to reduced activation of conventional T cells.
    Svensson H; Olofsson V; Lundin S; Yakkala C; Björck S; Börjesson L; Gustavsson B; Quiding-Järbrink M
    PLoS One; 2012; 7(2):e30695. PubMed ID: 22319577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function and recruitment of mucosal regulatory T cells in human chronic Helicobacter pylori infection and gastric adenocarcinoma.
    Enarsson K; Lundgren A; Kindlund B; Hermansson M; Roncador G; Banham AH; Lundin BS; Quiding-Järbrink M
    Clin Immunol; 2006 Dec; 121(3):358-68. PubMed ID: 16934529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APC
    Akeus P; Szeponik L; Ahlmanner F; Sundström P; Alsén S; Gustavsson B; Sparwasser T; Raghavan S; Quiding-Järbrink M
    Cancer Immunol Immunother; 2018 Jul; 67(7):1067-1077. PubMed ID: 29671006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treg-cell depletion promotes chemokine production and accumulation of CXCR3(+) conventional T cells in intestinal tumors.
    Akeus P; Langenes V; Kristensen J; von Mentzer A; Sparwasser T; Raghavan S; Quiding-Järbrink M
    Eur J Immunol; 2015 Jun; 45(6):1654-66. PubMed ID: 25754875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human colonic myofibroblasts promote expansion of CD4+ CD25high Foxp3+ regulatory T cells.
    Pinchuk IV; Beswick EJ; Saada JI; Boya G; Schmitt D; Raju GS; Brenmoehl J; Rogler G; Reyes VE; Powell DW
    Gastroenterology; 2011 Jun; 140(7):2019-30. PubMed ID: 21376048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral regulatory T cells from colon cancer patients comprise several activated effector populations.
    Szeponik L; Ahlmanner F; Sundström P; Rodin W; Gustavsson B; Bexe Lindskog E; Wettergren Y; Quiding-Järbrink M
    BMC Immunol; 2021 Aug; 22(1):58. PubMed ID: 34407765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition and plasticity of triple-negative breast carcinoma-infiltrating regulatory T cells.
    Cai B; Ma P; Ding P; Sun DW; Bu Q; Zhang J
    APMIS; 2020 Mar; 128(3):260-269. PubMed ID: 31811667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthy Preterm Newborns Show an Increased Frequency of CD4(+) CD25(high) CD127(low) FOXP3(+) Regulatory T Cells with a Naive Phenotype and High Expression of Gut-Homing Receptors.
    Rennó C; Nadaf MI; Zago CA; Carneiro-Sampaio M; Palmeira P
    Scand J Immunol; 2016 Jun; 83(6):445-55. PubMed ID: 27007547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells.
    Zhou J; Bashey A; Zhong R; Corringham S; Messer K; Pu M; Ma W; Chut T; Soiffer R; Mitrovich RC; Lowy I; Ball ED
    Biol Blood Marrow Transplant; 2011 May; 17(5):682-92. PubMed ID: 20713164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.
    Kutukculer N; Azarsiz E; Aksu G; Karaca NE
    Int J Immunopathol Pharmacol; 2016 Jun; 29(2):241-51. PubMed ID: 26684629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory T cells specifically suppress conventional CD8αβ T cells in intestinal tumors of APC
    Szeponik L; Akeus P; Rodin W; Raghavan S; Quiding-Järbrink M
    Cancer Immunol Immunother; 2020 Jul; 69(7):1279-1292. PubMed ID: 32185408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APC(Min/+) mice.
    Akeus P; Langenes V; von Mentzer A; Yrlid U; Sjöling Å; Saksena P; Raghavan S; Quiding-Järbrink M
    Cancer Immunol Immunother; 2014 Aug; 63(8):807-19. PubMed ID: 24777614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionizing radiation modulates the phenotype and function of human CD4+ induced regulatory T cells.
    Beauford SS; Kumari A; Garnett-Benson C
    BMC Immunol; 2020 Apr; 21(1):18. PubMed ID: 32299365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human Th1-like regulatory CD4+ T cells by an intrinsic IFN-γ- and T-bet-dependent pathway.
    Zheng J; Liu Y; Qin G; Lam KT; Guan J; Xiang Z; Lewis DB; Lau YL; Tu W
    Eur J Immunol; 2011 Jan; 41(1):128-39. PubMed ID: 21182084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depletion of CD4+CD25+ regulatory T cells enhances interleukin-2-induced antitumor immunity in a mouse model of colon adenocarcinoma.
    Imai H; Saio M; Nonaka K; Suwa T; Umemura N; Ouyang GF; Nakagawa J; Tomita H; Osada S; Sugiyama Y; Adachi Y; Takami T
    Cancer Sci; 2007 Mar; 98(3):416-23. PubMed ID: 17270031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.
    Ha D; Tanaka A; Kibayashi T; Tanemura A; Sugiyama D; Wing JB; Lim EL; Teng KWW; Adeegbe D; Newell EW; Katayama I; Nishikawa H; Sakaguchi S
    Proc Natl Acad Sci U S A; 2019 Jan; 116(2):609-618. PubMed ID: 30587582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and functional characteristics of CD4+ CD39+ FOXP3+ and CD4+ CD39+ FOXP3neg T-cell subsets in cancer patients.
    Schuler PJ; Schilling B; Harasymczuk M; Hoffmann TK; Johnson J; Lang S; Whiteside TL
    Eur J Immunol; 2012 Jul; 42(7):1876-85. PubMed ID: 22585562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
    Ohue Y; Nishikawa H
    Cancer Sci; 2019 Jul; 110(7):2080-2089. PubMed ID: 31102428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome.
    Gobert M; Treilleux I; Bendriss-Vermare N; Bachelot T; Goddard-Leon S; Arfi V; Biota C; Doffin AC; Durand I; Olive D; Perez S; Pasqual N; Faure C; Ray-Coquard I; Puisieux A; Caux C; Blay JY; Ménétrier-Caux C
    Cancer Res; 2009 Mar; 69(5):2000-9. PubMed ID: 19244125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumors establish resistance to immunotherapy by regulating T
    Marshall LA; Marubayashi S; Jorapur A; Jacobson S; Zibinsky M; Robles O; Hu DX; Jackson JJ; Pookot D; Sanchez J; Brovarney M; Wadsworth A; Chian D; Wustrow D; Kassner PD; Cutler G; Wong B; Brockstedt DG; Talay O
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33243932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.